Given that tumor‐infiltrating T cells are the main antitumor response effectors, by the infiltration of CD4+ and CD8+ T cells and depletion of Treg cells to reverse the immunosuppression may explain the synergistic efficacy of the CPMV+CPA combination therapy. The gene discussed is CD4; the disease is neoplasm.